Marek Mráz

3.9k total citations · 1 hit paper
48 papers, 2.4k citations indexed

About

Marek Mráz is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Marek Mráz has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 21 papers in Immunology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Marek Mráz's work include Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (14 papers) and MicroRNA in disease regulation (11 papers). Marek Mráz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (14 papers) and MicroRNA in disease regulation (11 papers). Marek Mráz collaborates with scholars based in Czechia, United States and Austria. Marek Mráz's co-authors include Šárka Pospı́šilová, Gabriela Mladonická Pavlasová, Jiřı́ Mayer, Václav Šeda, Karla Malinová, Branislav Kusenda, Michael Doubek, Thomas J. Kipps, Martin Trbušek and Yvona Brychtová and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Marek Mráz

48 papers receiving 2.4k citations

Hit Papers

The regulation and function of CD20: an “enigma” of B-cel... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
    2020 255 citations Gabriela Mladonická Pavlasová, Marek Mráz Haematologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Mráz Czechia 24 1.2k 917 702 650 551 48 2.4k
Rajeev Vibhakar United States 33 2.1k 1.7× 760 0.8× 628 0.9× 421 0.6× 297 0.5× 98 2.9k
Raquel Malumbres Spain 19 1.4k 1.1× 1.0k 1.1× 157 0.2× 955 1.5× 436 0.8× 31 2.6k
Martin Janz Germany 23 1.3k 1.0× 400 0.4× 247 0.4× 781 1.2× 597 1.1× 47 2.5k
Hai T. Ngo United States 25 1.3k 1.0× 465 0.5× 544 0.8× 379 0.6× 456 0.8× 72 2.2k
Erin Hertlein United States 20 774 0.6× 231 0.3× 768 1.1× 551 0.8× 517 0.9× 48 1.7k
Elizabeth H. Stover United States 16 1.2k 1.0× 414 0.5× 422 0.6× 508 0.8× 350 0.6× 46 2.7k
Raquel Villuendas Spain 29 812 0.7× 270 0.3× 567 0.8× 361 0.6× 1.1k 2.1× 47 2.4k
Rossano Cesari United States 20 1.1k 0.9× 268 0.3× 438 0.6× 443 0.7× 250 0.5× 34 2.1k
Kevin Barton United States 21 1.8k 1.4× 384 0.4× 261 0.4× 1.0k 1.5× 363 0.7× 50 3.2k
Nabendu Pore United States 17 1.4k 1.1× 1.1k 1.2× 181 0.3× 244 0.4× 139 0.3× 26 2.3k

Countries citing papers authored by Marek Mráz

Since Specialization
Citations

This map shows the geographic impact of Marek Mráz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Mráz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Mráz more than expected).

Fields of papers citing papers by Marek Mráz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Mráz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Mráz. The network helps show where Marek Mráz may publish in the future.

Co-authorship network of co-authors of Marek Mráz

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Mráz. A scholar is included among the top collaborators of Marek Mráz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Mráz. Marek Mráz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mráz, Marek, et al.. (2024). FoxO1 signaling in B cell malignancies and its therapeutic targeting. FEBS Letters. 599(20). 2911–2931. 2 indexed citations
2.
Torres, Marcelo D. T., Floriana Cappiello, Katy Jeannot, et al.. (2024). Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities. Journal of Medicinal Chemistry. 67(16). 14040–14061. 9 indexed citations
3.
Khirsariya, Prashant, et al.. (2022). Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides. Journal of Medicinal Chemistry. 65(7). 5701–5723. 10 indexed citations
4.
Mráz, Marek, et al.. (2020). Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Frontiers in Oncology. 10. 591577–591577. 56 indexed citations
5.
Černá, Kateřina Amruz, et al.. (2019). Oct4-mediated reprogramming induces embryonic-like microRNA expression signatures in human fibroblasts. Scientific Reports. 9(1). 15759–15759. 13 indexed citations
6.
Khirsariya, Prashant, Marek Borský, Jan Verner, et al.. (2019). Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. 104(12). 2443–2455. 22 indexed citations
7.
Černá, Kateřina Amruz, Jan Oppelt, Václav Šeda, et al.. (2018). MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells. Leukemia. 33(2). 403–414. 42 indexed citations
8.
Janíková, Andrea, et al.. (2018). New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. Seminars in Oncology. 45(5-6). 291–302. 34 indexed citations
9.
Pavlasová, Gabriela Mladonická, Marek Borský, Veronika Svobodová, et al.. (2018). Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. Leukemia. 32(9). 2028–2031. 20 indexed citations
10.
Malčíková, Jitka, Kateřina Staňo Kozubík, Boris Tichý, et al.. (2014). Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. Leukemia. 29(4). 877–885. 106 indexed citations
11.
Navrkalová, Veronika, Jana Kmínková, Jitka Malčíková, et al.. (2013). ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin. Haematologica. 98(7). 1124–1131. 26 indexed citations
12.
Mráz, Marek, Kateřina Staňo Kozubík, Karla Plevová, et al.. (2013). The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leukemia Research. 37(7). 802–808. 11 indexed citations
13.
Raa, Doreen te, Jitka Malčíková, Marek Mráz, et al.. (2012). Assessment of p53 Functionality in Chronic Lymphocytic Leukemia by Different Assays; An Eric-Wide Approach.. Blood. 120(21). 2872–2872. 1 indexed citations
14.
Verner, Jan, Šárka Pavlová, Boris Tichý, et al.. (2012). Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation. Experimental Hematology. 40(11). 899–905.e5. 6 indexed citations
15.
Mráz, Marek, Šárka Pospı́šilová, Karla Malinová, Ivo Šlapák, & Jiřı́ Mayer. (2009). MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leukemia & lymphoma. 50(3). 506–509. 86 indexed citations
16.
Mráz, Marek, Karla Malinová, Jiřı́ Mayer, & Šárka Pospı́šilová. (2009). MicroRNA isolation and stability in stored RNA samples. Biochemical and Biophysical Research Communications. 390(1). 1–4. 176 indexed citations
17.
Kusenda, Branislav, et al.. (2006). MicroRNA BIOGENESIS, FUNCTIONALITY AND CANCER RELEVANCE. Biomedical Papers. 150(2). 205–215. 129 indexed citations
18.
Mráz, Marek, S Aull, Matthias J. Feucht, et al.. (1993). [Tension headache--new evaluation of symptomatology based on International Headache Society diagnostic criteria].. PubMed. 105(2). 42–52. 4 indexed citations
19.
Dal‐Bianco, Peter, et al.. (1991). Galanthamine treatment in Alzheimer’s disease. PubMed. 33. 59–63. 34 indexed citations
20.
Lind, Christopher R. P., et al.. (1991). Early diagnosis of Alzheimer dementia?. PubMed. 33. 53–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajeev Vibhakar Breakdown of academic impact, for papers by Raquel Malumbres Breakdown of academic impact, for papers by Martin Janz Breakdown of academic impact, for papers by Hai T. Ngo Breakdown of academic impact, for papers by Erin Hertlein Breakdown of academic impact, for papers by Elizabeth H. Stover Breakdown of academic impact, for papers by Raquel Villuendas Breakdown of academic impact, for papers by Rossano Cesari Breakdown of academic impact, for papers by Kevin Barton Breakdown of academic impact, for papers by Nabendu Pore
Rankless by CCL
2026